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Abstract
Postpartum uterine infections reduce reproductive efficiency and have significant animal welfare
and economic consequences. Postpartum uterine infections are classified as nonspecific, but
Arcanobacterium pyogenes and Escherichia coli are usually associated with them in cattle and sheep.
Pyometra is the most common type of uterine infection in dairy cattle, and it is detected almost
exclusively in cows with active corpora lutea. Luteal progesterone typically down-regulates uterine
immune functions and prevents the uterus from resisting infections. Progesterone also can down-
regulate uterine eicosanoid synthesis. This seems to be a critical event in the onset of uterine
infections, because eicosanoids can up-regulate immune cell functions in vitro. In addition,
exogenous prostaglandin F2 alpha stimulates uterine secretion of prostaglandin F2 alpha and
enhances immune functions in vivo. Thus, one may hypothesize that eicosanoids can override the
negative effects of progesterone and that the up-regulatory effects of exogenous prostaglandin F2
alpha allow the uterus to resolve an infection, regardless of progesterone concentrations. Based
on the results of studies to test that hypothesis, cows, sheep, and pigs in various physiological
statuses are resistant to intrauterine infusions of Arcanobacterium pyogenes and Escherichia coli,
unless progesterone concentrations are increased. In sheep and pigs, exogenous prostaglandin F2
alpha stimulates uterine production of prostaglandin F2 alpha and allows the uterus to resolve
Arcanobacterium pyogenes-Escherichia coli-induced infections, even when progesterone is maintained
at luteal phase concentrations before and after treatment. Prostaglandin F2 alpha is a
proinflammatory molecule that stimulates the production of various proinflammatory cytokines,
and it may enhance uterine production of leukotriene B4. Proinflammatory cytokines and
leukotriene B4 enhance phagocytosis and lymphocyte functions. Even though there are clear
associations among prostaglandin F2 alpha, leukotriene B4, proinflammatory cytokines,
phagocytosis, and lymphocyte functions, the mechanism of action of exogenous prostaglandin F2
alpha in overriding the down-regulatory effects of progesterone and resolving uterine infections has
not been elucidated. Defining this mechanism should yield new prevention and treatment strategies
for uterine infections that do not rely on antibiotic and antimicrobial compounds.
Review
Background
Nonspecific uterine infections reduce the reproductive
efficiency of livestock [1-3]. They are called nonspecific
because the initial colonizing bacterium is not known,
and the specific bacteria causing the signs of infection are
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not known [2,4-6]. Even though numerous bacteria, in a
variety of combinations, have been isolated from infected
uteri, Arcanobacterium pyogenes and Escherichia coli are usu-
ally associated with uterine infections in cattle and sheep
[3-6].
Estimates of the annual incidence of uterine infections in
postpartum animals in herds and flocks range from 10 to
50% of the dairy cattle [1,2], 20 to 75% of the dairy buf-
faloes [7], and 5 to 10% of the dairy sheep [8]. Published
estimates of the incidence of analogous uterine infections,
as opposed to the mastitis, metritis, agalactica syndrome,
in postpartum pigs are not available. However, swine herd
managers and veterinarians often state that they are "com-
mon" (personal communications). Despite the published
estimates for cattle, buffaloes, and sheep, the "true" inci-
dence of uterine infections is not known for any livestock
species because detection and diagnosis are often inaccu-
rate and reporting is not mandatory.
In the United States, intramuscular (i.m.) injections of
prostaglandin F2α  (PGF2α) have become the preferred
treatment for pyometra in cattle [2]. Pyometra is the most
common type of uterine infection in dairy cattle, and it is
the one most often associated with reduced reproductive
performance [2]. Pyometra typically develops just after
the onset of luteal function during the postpartum period
[2]. Apparently, bacteria that are normally found in live-
stock environments are introduced during or after calving,
particularly when cows with dystocia are assisted and
when retained fetal membranes are removed manually
[2]. In cows that later develop uterine infections, the bac-
teria seem to reside in the uterus, without proliferating
into an infection, until luteal progesterone down-regu-
lates immune functions. Then the bacteria proliferate and
create a pathological condition. The infections usually
persist until luteolysis. The resultant reduction in proges-
terone concentrations seems to permit the uterine
immune system to up-regulate and resolve the infection.
Thus, exogenous PGF2α is used to induce luteolysis and
clear uterine infections, although the true mechanism of
action of PGF2α in eliminating uterine infections is not
known. In fact, PGF2α seems to have effects that are inde-
pendent of its effects on corpus luteum function.
Even though exogenous PGF2α has become the preferred
treatment, intrauterine and systemic antibiotic treatments
are common in the United States and in other countries
[2,9]. General concerns about the relationship between
antibiotic use in livestock and the potential for accelerat-
ing the evolution of antibiotic-resistant strains of bacteria
have aimed our research at determining whether nonanti-
biotic, native compounds can be used to enhance host
immunity and prevent or resolve uterine infections.
Because of the pivotal role of progesterone in converting
the uterus from resistant to susceptible to infections,
understanding the mechanism of action of progesterone
is essential for developing methods for enhancing the
ability of the uterus to manage pathogenic bacteria. Thus,
the purpose of this article is to briefly review the role of
progesterone in making the uterus susceptible to infec-
tions and describe how eicosanoids may be used to over-
ride the immunosuppressive effects of progesterone.
Progesterone
Data from numerous studies that have been published
over the last 50 years indicate that cattle, sheep, and pigs
are resistant to uterine infections when progesterone con-
centrations are basal, and they are susceptible when pro-
gesterone concentrations are increased [10-15]. For
example, spontaneous uterine infections in dairy cows do
not usually develop until after formation of the first post-
partum corpus luteum, although bacterial contamination
can be sufficient to induce the onset of puerperal metritis
very soon after calving when progesterone concentrations
are basal [1,2,15]. Postpartum beef cows that received
intrauterine infusions of A. pyogenes and E. coli when pro-
gesterone concentrations were basal did not develop uter-
ine infections, whereas all cows developed uterine
infections when the bacteria were infused after the onset
of luteal function and progesterone concentrations had
begun to increase [6]. The same was true for postpartum
ewes (i.e., female sheep) with spontaneous onset of luteal
function and for postpartum ewes that had been ovariect-
omized and treated i.m. with progesterone [16,17]. In
addition, none of the ewes or gilts (i.e., nulliparous pigs)
that received intrauterine infusions of A. pyogenes and E.
coli during estrus developed uterine infections, but all of
the ewes and gilts that received A. pyogenes and E. coli infu-
sions during the luteal phase of the estrous cycle devel-
oped uterine infections [18-20].
Lymphocyte proliferation in vitro has been used as a gen-
eral measure of immune responsiveness, even though
neutrophils, which are much more difficult to evaluate,
probably have a greater role in the initial response to bac-
teria that enter the uterus [21-25]. Unstimulated, conca-
navalin A (Con A)-stimulated (stimulates T-cells), and
lipopolysaccharide (LPS)-stimulated (stimulates B-cells)
proliferation were greater for lymphocytes collected from
postpartum ewes that had been ovariectomized before the
onset of luteal function than was proliferation of lym-
phocytes collected from ewes with spontaneous luteal
function and increased progesterone [17]. (In contexts,
such as in the previous sentence, greater, increased,
decreased, etc. refers to an event with P < 0.05). Unstimu-
lated and Con-A stimulated lymphocyte proliferation
were greater for sesame oil-treated than for progesterone-
treated postpartum ewes [17]. Unstimulated, Con A-stim-
ulated, and LPS-stimulated proliferation were greater forReproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/117
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lymphocytes collected from estrous ewes than from luteal
phase ewes, and unstimulated and Con A-stimulated lym-
phocyte proliferation were greater for estrous gilts than for
luteal phase gilts [18,20]. Indeed, several authors have
reported that progesterone suppresses lymphocyte prolif-
eration [26-29], and this effect of progesterone was asso-
ciated with the inability of the uterus to prevent the
development of infections.
The previous examples clearly support the idea that pro-
gesterone converts the uterus from an organ that is resist-
ant to one that is susceptible to infections. Data from the
studies selected for the examples, as well as reports from
other authors, also support the idea that, when progester-
one concentrations are basal and bacterial contamination
is not severe enough to overwhelm uterine defenses (i.e.,
puerperal metritis is not an issue), the uterus "defaults" to
resistant to infections. We have referred to this as a "pro-
tected period," although we acknowledge that some
threshold, albeit unknown, load of bacteria will over-
whelm uterine defenses. Basal progesterone and basal
estradiol concentrations are two characteristics of the pro-
tected period, and we assume that "basal" immune
responses are usually able to prevent bacteria from prolif-
erating into a pathological condition. We have used post-
partum and seasonally anestrous ewes to determine
whether the uterus is, in fact, protected.
In two studies, none of the autumn-lambing ewes that
were ovariectomized on day 9 or day 14 postpartum,
before spontaneous onset of luteal function and increases
in progesterone concentrations, and treated i.m. with can-
ola oil or safflower oil developed infections after intrau-
terine infusion of A. pyogenes and  E. coli [16,17]. By
contrast, all of the ewes in the two studies with spontane-
ous luteal function and all of the ewes treated i.m. with
progesterone in canola oil or safflower oil developed
infections after intrauterine infusion of A. pyogenes and E.
coli  [16,17]. For the ewes ovariectomized on day 14,
PGF2α concentrations in vena caval blood were greatest in
ewes with the least vena caval progesterone, and PGF2α
was least in the ewes with the greatest progesterone [17].
Vena caval blood was collected through catheters that
were positioned just cranial to the entry of uteroovarian
blood [30]. Indeed, 6α-methyl-17α-hydroxyprogesterone
acetate (a progestogen commonly used to control the
estrous cycle) reduced uterine secretion of PGF2α [31].
Ovariectomy increased and exogenous progesterone
decreased Con A-stimulated lymphocyte proliferation,
and ovariectomy increased LPS-stimulated lymphocyte
proliferation [17]. The results were less clear for the ewes
ovariectomized on day 9, but exogenous progesterone
seemed to have some suppressive effects on lymphocyte
proliferation [16]. Overall, suppressed PGF2α secretion,
suppressed lymphocyte proliferation in vitro, and
increased progesterone were associated with the inability
of the uterus to prevent infections. When progesterone
concentrations were basal, the "default" immune status of
the ewes was adequate to prevent uterine infections.
In another study, seasonally anestrous ewes were used to
determine whether, in the long-term absence of ovarian
progesterone, the uterus was resistant to infections [32].
The ewes in this study had not been detected in estrus for
at least three months, had basal endogenous progesterone
concentrations, and had no ovarian follicles large enough
to be estrogen active. None of the control ewes developed
infections after intrauterine infusion of A. pyogenes and E.
coli, whereas all of the progesterone-treated ewes devel-
oped infections after intrauterine A. pyogenes and E. coli
infusions [32]. Bacteria were infused into the uterus two
days before commencement of progesterone injections to
determine whether the uterus would eliminate the bacte-
ria soon after they were introduced. The bacteria were
apparently able to survive in the uterus until exogenous
progesterone prevented the uterus from suppressing their
proliferation. Results from these studies with postpartum
and seasonally anestrous ewes support the hypothesis
that, when progesterone and estradiol are basal, the uterus
is resistant to infectious bacteria, although the uterus does
not seem to eliminate bacteria as soon as they arrive. A
direct effect of estradiol on the resistance or susceptibility
of the uterus in cattle, sheep, and pigs to infections has not
been established, but authors usually acknowledge the
temporal associations between reductions in progester-
one, increases in estradiol, and resistance to uterine infec-
tions [18,20]. Thus, because the role of estradiol has not
been established and because progesterone unequivocally
down-regulates uterine immune functions, progesterone
seems to be the ovarian steroid that primarily determines
whether the uterus can prevent bacteria from proliferating
into an infection.
Progesterone and Eicosanoids
Eicosanoids, including prostaglandins and leukotrienes,
belong to a family of compounds that are synthesized
from arachidonic acid through the cyclooxygenase and
lipoxygenase pathways [33,34]. The family is large; so
only selected eicosanoids will be discussed.
Peripheral progesterone and 13,14-dihydro-15-keto-
PGF2α (PGFM) concentrations were quantified in postpar-
tum dairy cows to characterize the relationships among
progesterone, PGFM, and onset of uterine infections
[15,35,36]. 13,14-Dihydro-15-keto-PGF2α is a metabolite
of PGF2α with a half-life of approximately 15 min, com-
pared with approximately 1 min for PGF2α [37,38]. Dur-
ing the postpartum period, jugular concentrations of
PGFM are a close reflection of uterine secretion of PGF2α;
however, that does not seem to be the case during theReproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/117
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estrous cycle, when the uterus produces considerably less
PGF2α [31,37,39]. The results of studies with postpartum
dairy cows indicated that PGFM concentrations were less
in cows that later developed uterine infections than they
were in cows that did not develop uterine infections
[15,36]. Only small increases in progesterone, presuma-
bly luteal, were necessary to initiate the onset of uterine
infections [15], and PGFM concentrations increased at the
onset of uterine infections [35]. The increase in PGFM
most likely reflected a uterine inflammatory response to
the proliferation of bacteria and release of endotoxin
[40,41].
One interpretation of the results of the studies with dairy
cows and sheep is that uterine PGF2α production is related
to the ability of the uterus to prevent or resolve infections.
Moreover, one may speculate that progesterone-PGF2α
interactions modulate the ability of the uterus to prevent
infections. Stated more directly, progesterone can down-
regulate immune functions and prevent the uterus from
resisting infections, whereas PGF2α, and probably other
eicosanoids such as leukotriene B4 (LTB4), can up-regulate
immune functions and override the effects of progester-
one. In fact, in vitro experiments indicate that PGF2α,
LTB4, 5-hydroxyeicosatetraenoic acid, 15-hydroxyeicosa-
tetraenoic acid, and lipoxin B4 are chemoattractant to neu-
trophils [42]. Neutrophils are thought to be the initial
defense against pathogens that enter the uterus, and sup-
pressed neutrophil functions are thought to predispose
the uterus to infections [22,23,25]. Prostaglandin E2 can
suppress a number of immune functions, including neu-
trophil functions, and predispose cows to uterine infec-
tions [24]. Progesterone-eicosanoid interactions are
clearly broader than just PGF2α interactions. However,
because of the large number of compounds that can inter-
act with progesterone and affect immune functions, our
research has focused on progesterone-PGF2α interactions.
Even though exogenous PGF2α will induce luteolysis and
allow the uterus to clear infections, authors have men-
tioned that exogenous PGF2α helped resolve uterine infec-
tions in cows that did not have any evidence of luteal
function [6]. Clinical veterinarians often speculate that
exogenous PGF2α  stimulates uterine contractions that
expel the bacteria (personal communications). But this
ignores the issue that bacteria are likely to remain in the
uterus and will be present when luteal function is reiniti-
ated, and it ignores the fact that literature is not available
to substantiate the idea that uterine contractions cleanse
the uterus. Indeed, a study with mares indicates that uter-
ine contractions may reduce the fluid associated with uter-
ine infections, but uterine contractions do no seem to
eliminate the bacteria [43]. However, one can reason,
based on a good deal of literature, that exogenous PGF2α
has direct effects on uterine immune functions.
A key point, from a mechanism-of-action perspective, is
that the direct effects of exogenous PGF2α  on uterine
immune functions and the effects of PGF2α on luteal func-
tion and progesterone concentrations are completely con-
founded. In other words, is exogenous PGF2α effective
because it stimulates immune functions, or is exogenous
PGF2α effective because it removes progesterone? We have
conducted studies with sheep and pigs to address these
questions.
Prostaglandin F2α  is not luteolytic in pigs until after
approximately day 12 of the estrous cycle [44]. We used
this information to determine whether PGF2α had direct
effects on uterine immune functions. Sows (i.e., parous
pigs) were assigned to a 2 × 2 factorial array of treatments
(n = 6 sows/group); intrauterine infusion of A. pyogenes
and  E. coli (i.e., bacteria vs. phosphate-buffered saline
[PBS]) and PGF2α (i.e., 10 mg of PGF2α vs. saline) were the
two main effects. Bacteria or PBS was infused on day 7 of
the estrous cycle, and PGF2α or saline was injected i.m.
once on day 9 of the estrous cycle. Uteri were collected on
day 11 of the same estrous cycle. Vena caval blood was
collected throughout the experiment. Vena caval proges-
terone concentrations did not differ among groups and
averaged 64 ng/mL during the study, which indicates that
PGF2α did not affect luteal function. Vena caval estradiol-
17β concentrations did not differ among groups and aver-
aged 1 ng/mL, which is a typical luteal phase concentra-
tion. The PGF2α  injection increased vena caval PGF2α
concentrations, and this is consistent with the results of
studies with sheep in which exogenous PGF2α stimulated
uterine secretion of PGF2α [37]. Exogenous PGF2α also
enhanced unstimulated and LPS-stimulated lymphocyte
proliferation, and it increased vena caval PGE2 concentra-
tions. None of the PBS-treated sows developed uterine
infections, but all of the bacteria-treated sows developed
uterine infections. Based on the volume of sediment,
which is composed of leucocytes and bacteria, in the uter-
ine flushings collected on day 11 and the ability to culture
of A. pyogenes and E. coli from the flushings, the PGF2α-
treated sows were resolving the uterine infections (sedi-
ment was 70% of total flushing volume for bacteria-
saline, 30% for bacteria-PGF2α, and <5% for PBS-saline
and PBS-PGF2α sows). Based on these results, PGF2α treat-
ment allowed the uterus to begin resolving the infections,
even though progesterone remained at luteal phase con-
centrations and estradiol concentrations were basal.
Because PGF2α is luteolytic in sheep after approximately
day 4 of the estrous cycle, we used ovariectomized, pro-
gesterone-treated ewes to test the hypothesis that PGF2α
has effects on uterine immunity that are independent of
progesterone concentrations. Ewes were assigned to a 2 ×
2 × 2 factorial array of treatments (n = 8 ewes/group); ova-
riectomy (i.e., ovariectomy vs. sham procedure), proges-Reproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/117
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terone (5 mg of progesterone at 12-hour intervals vs.
sesame oil diluent at the same times), and PGF2α (15 mg
of PGF2α vs. saline) were main effects. On the day of estrus
(i.e., day 0), ewes were either ovariectomized or a sham
procedure was performed. Either progesterone or sesame
oil was injected i.m. from day 0 through day 11. Catheters
were positioned in the vena cava on day 5, and vena caval
blood was collected from then until the end of the exper-
iment. On day 6, all ewes received intrauterine infusions
of A. pyogenes and E. coli. Prostaglandin F2α or saline was
injected i.m. on day 9, and uteri were collected on day 12.
Vena caval progesterone concentrations in all eight groups
of ewes behaved as anticipated. For example, progester-
one concentrations in sham ovariectomy-sesame oil-
saline ewes were indicative of a "normal" luteal phase.
Prostaglandin F2α induced luteolysis and reduced proges-
terone concentrations to basal values in ewes that did not
receive exogenous progesterone. Ovariectomy reduced
progesterone to basal concentrations, and exogenous pro-
gesterone maintained or increased (i.e., in sham ovariect-
omized, progesterone-treated ewes) progesterone
concentrations. As expected, exogenous PGF2α increased
vena caval PGF2α concentrations. All of the sham-ovariec-
tomy ewes developed uterine infections. However, based
on sediment volume and ability to culture A. pyogenes and
E. coli from the uterine flushings, the sham-oil-saline ewes
and the sham-oil-PGF2α ewes were resolving (sediment
volume approximately 8%) the infections by day 12. The
sham-progesterone-saline ewes had severe uterine infec-
tions on day 12 (sediment volume of 28%, which is con-
siderably greater than usually seen for sheep with uterine
infections), but the sham-progesterone-PGF2α ewes were
resolving the infections on day 12 (sediment volume of
approximately 15% vs. the 28%). The ovariectomy-oil-
saline ewes did not have uterine infections on day 12 (sed-
iment volume of 5%), but the ovariectomy-progesterone-
saline ewes had typical infections (sediment volume of
approximately 16%) on day 12. The ovariectomy-oil-
PGF2α ewes did not have uterine infections on day 12
(sediment volume of approximately 2%), and the ovariec-
tomy-progesterone-PGF2α ewes had nearly resolved the
infections (sediment volume of approximately 4%) by
day 12. Progesterone reduced unstimulated lymphocyte
proliferation, whereas exogenous PGF2α  increased
unstimulated, Con A-stimulated, and LPS-stimulated
lymphocyte proliferation. The results of this experiment
indicate that exogenous PGF2α enhances the ability of the
uterus to resolve infections, regardless of progesterone
concentrations. The ewes in this experiment and the sows
in the other experiment discussed received one injection
of PGF2α, and this was enough to begin resolving or to
nearly resolve the uterine infections. We have speculated
that a second injection of PGF2α 12 to 24 hours after the
first would resolve all of the induced infections, but that
possibility has not yet been evaluated experimentally.
Based on current literature, the ability of the uterus to
resist or to resolve uterine infections seems to be related to
the ability of the uterus to secrete PGF2α. Exogenous
PGF2α enables the uterus to resolve uterine infections,
even when circulating progesterone concentrations are
maintained at luteal phase concentrations or greater.
Thus, PGF2α can up-regulate immune functions and over-
ride the down-regulatory effects of progesterone.
Mechanisms
Progesterone and eicosanoids have a variety of independ-
ent effects on immune cell functions. The negative effects
of progesterone on immune functions have been reviewed
extensively, especially the effects of progesterone on the
synthesis of immunosuppressants and blocking factors,
and will not be reviewed in this article [26-28]. Instead,
this section will focus on relationships between progester-
one and eicosanoids, because manipulating this relation-
ship at the cellular or molecular level seems to have great
potential for preventing or resolving uterine infections in
livestock-production settings.
During estrus, when progesterone concentrations are
decreased and estradiol concentrations are increased, uter-
ine production of PGF2α is increased, endometrial LTB4
production is increased, and the uterus is normally able to
prevent infections from developing [45-48]. Uterine
PGF2α and LTB4 production decrease to basal within a few
days after estrus, when progesterone concentrations begin
to increase and the uterus again becomes susceptible to
infections [46,47,49]. Prostaglandin F2α enhanced neu-
trophil chemotaxis and the ability of neutrophils to ingest
bacteria, and LTB4 enhanced chemotaxis, random migra-
tion, and antibody-independent cell-mediated cytotoxic-
ity [42]. Prostaglandin F2α, which is considered a
proinflammatory molecule, may stimulate the produc-
tion of proinflammatory cytokines that enhance phagocy-
tosis and lymphocyte functions [19,50]. Leukotriene B4
may promote uterine involution and reduce the risk of
uterine infections in cows [49]. Exogenous PGF2α
increases uterine secretion of PGF2α and luteal production
of LTB4 [37,51]. Because definitive data are not available,
one can only speculate that PGF2α enhances uterine LTB4
production. However, nordihydroguaiaretic acid, which
inhibits lipoxygenase activity and LTB4 production, pro-
longed the luteal phase in cattle and sheep, and the uterus
seems to have mediated the effect [52,53]. The increase in
uterine PGF2α production after exogenous PGF2α probably
increases phospholipase A2 (PLA2) and cyclooxygenase 2
activities [54-56]. Increased PLA2  would increase the
amount of free arachidonic acid that could be used to pro-
duce cyclooxygenase (e.g., PGF2α and PGE2) and lipoxyge-
nase (e.g., LTB4) products. In addition, tumor-necrosis
factor α (TNFα), which mediates inflammatory and cyto-
toxic responses [40], stimulates endometrial PGF2α pro-Reproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/117
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duction, and PLA2 seems to mediate this effect [57,58].
Therefore, enhancing uterine secretion of PGF2α and LTB4
should up-regulate immune functions and enable the
uterus to prevent or resolve infections. Exogenous fen-
prostalene (i.e., a long-acting PGF2α  analogue), which
should increase uterine PGF2α secretion, injected subcuta-
neously once sometime between days 7 and 10 postpar-
tum reduced the incidence of endometritis in cows with
dystocia and/or retained fetal membranes [36]. A single
subcutaneous fenprostalene injection on the day
endometritis was detected (i.e., sometime between days
14 and 28 postpartum) reduced the interval from parturi-
tion to conception in dairy cows [36]. However, studies to
define the mechanisms of action of PGF2α in livestock
have not been reported. This seems to be a fruitful area of
study with considerable benefit to the livestock industries.
If the assertion that enhancing uterine secretion of PGF2α
and LTB4 will enable the uterus to resolve infections is cor-
rect, it means that PGF2α and LTB4 must override the
inhibitory effects of progesterone. In addition to its ability
to stimulate the production of immunosuppressants and
blocking factors, progesterone can stimulate prostaglan-
din E synthase activity and decrease the activity of a
number of proinflammatory molecules [26-28,59,60].
For example, progesterone suppresses the production of
IL-8, which promotes chemotaxis, superoxide release, and
granule release from phagocytic cells, in reproductive tis-
sues [61-65]. It may also suppress the production of IL-6,
which promotes B-cell differentiation and production of
acute-phase proteins [66]. In addition, progesterone
inhibits the production of IL-12, which induces inter-
feron-γ production and enhances natural killer-cell cyto-
toxicity, and PLA2, presumably via increased free
arachidonic acid, seems to mediate the effects of IL-12
[29]. Even though progesterone has a variety of inhibitory
effects, they are not always consistent among reports,
much of the research has only been conducted with in
vitro systems, and very little of the research has been
focused on the relationship between production of vari-
ous proinflammatory molecules and the ability of the
uterus in livestock to resistant or resolve infections.
Conclusions
Progesterone seems to be the primary ovarian steroid that
governs the ability of the uterus to resist infections. In live-
stock, progesterone typically down-regulates immune
functions and makes the uterus susceptible to infections.
Exogenous PGF2α increases uterine secretion of PGF2α,
and probably LTB4, and these two eicosanoids are associ-
ated with enhanced uterine immune responses and resist-
ance to infections. Even though progesterone and
eicosanoids affect a variety of proinflammatory molecules
that can alter uterine immune responses, the role of these
molecules in determining whether the uterus in livestock
is resistant or susceptible to infections has not been eluci-
dated. Indeed, determining how uterine PGF2α is able to
stimulate the uterus to resolve infections, even when pro-
gesterone concentrations are increased, should be impor-
tant to scientists and clinicians working to understand the
underlying causes of uterine infections. Information from
this line of research should yield important new preven-
tion and treatment strategies for uterine infections that do
not rely on antibiotic and antimicrobial compounds.
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